July 24 Management tracks: GSK, Goldman Sachs, Ziopharm and Alkahest

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) announced Wednesday that it has appointed Jonathan Symonds as non-executive chairman to succeed Philip Hampton, effective Sept. 1. Symonds is deputy group chairman at HSBC and has served as CFO Novartis AG (NYSE:NVS; SIX:NOVN) and AstraZeneca plc (LSE:AZN; NYSE:AZN). GSK said in January Hampton would step down ahead of the planned split of its consumer healthcare and innovative R&D businesses.

Goldman Sachs hired Samuel Thong as managing director and chairman and co-head of its Asia ex-Japan investment banking group. Thong was executive director at Morgan Stanley covering healthcare investment banking in Asia and previously worked at BofA Merrill Lynch...